Related references
Note: Only part of the references are listed.Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision
Ashif Iqubal et al.
LIFE SCIENCES (2019)
Cyclophosphamide-induced hemorrhagic cystitis in young patients with solid tumors: A single institution study
Yoshimasa Saito et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2018)
Hemorrhagic Radiation Cystitis
William M. Mendenhall et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2015)
Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival
L. E. Lunde et al.
BONE MARROW TRANSPLANTATION (2015)
Incidence of Cyclophosphamide-induced Urotoxicity and Protective Effect of Mesna in Rheumatic Diseasesle
Neslihan Yilmaz et al.
JOURNAL OF RHEUMATOLOGY (2015)
Preventive Measures for Cyclophosphamide-Related Hemorrhagic Cystitis in Blood and Bone Marrow Transplantation: An Italian Multicenter Retrospective Study
Silvia Gonella et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2015)
SAT0538 Cyclophosphamide Induced Bladder Toxicity and Protective Effect of 2-Mercaptoethane Sulfonate (MESNA) in Systemic Autoimmune Disorders
N. Yilmaz et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Low-Dose Cyclophosphamide Associated with Hemorrhagic Cystitis in a Breast Cancer Patient
Ariela Marshall et al.
BREAST JOURNAL (2012)
Incidence and Prevention of Bladder Toxicity From Cyclophosphamide in the Treatment of Rheumatic Diseases A Data-Driven Review
Paul A. Monach et al.
ARTHRITIS AND RHEUMATISM (2010)
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
Martee L. Hensley et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cyclophosphamide and cancer: golden anniversary
Ashkan Emadi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation
K Tsuboi et al.
BONE MARROW TRANSPLANTATION (2003)
2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: Clinical practice guidelines of the American Society of Clinical Oncology
LM Schuchter et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A new regimen of MESNA (2-mercaptoethanesulfonate) effectively prevents cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplant recipients
NH Khojasteh et al.
TRANSPLANTATION PROCEEDINGS (2000)
Share Paper
